Arachidonic acid pathway: A molecular target in human testicular cancer (review)

Molecular Medicine Reports

Volumn 2, Issue 4, 2009, Pages 527-531

  Matsuyama, Masahide ^a   Yoshimura, Rikio ^a,b  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b OSAKA CITY UNIVERSITY HOSPITAL   (Japan)

Author keywords

Cyclooxygenase; Lipoxygenase; Peroxisome proliferator activator receptor ; Testicular cancer

Indexed keywords

5 HYDROPEROXY 6,8,11,14 ICOSATETRAENOIC ACID; ARACHIDONIC ACID; CYCLOOXYGENASE 2 INHIBITOR; IBUPROFEN; INDOMETACIN; ISOENZYME; LEUKOTRIENE; LIPOXYGENASE; LIPOXYGENASE INHIBITOR; MELOXICAM; N (2 CYCLOHEXYLOXY 4 NITROPHENYL)METHANESULFONAMIDE; NAPROXEN; NIMESULIDE; NONSTEROID ANTIINFLAMMATORY AGENT; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR DELTA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PIROXICAM;

ADIPOCYTE; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; BLOOD VESSEL; CANCER CELL; CANCER TISSUE; CARCINOGENESIS; CELL DIFFERENTIATION; CELL GROWTH; CELL VIABILITY; CHEMOPROPHYLAXIS; CHORIOCARCINOMA; DOSE RESPONSE; EMBRYONAL CARCINOMA; EPITHELIUM; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOMODULATION; ISOENZYME ANALYSIS; LIPID METABOLISM; PROTEIN EXPRESSION; REGULATORY MECHANISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; SEMINOMA; TARGET CELL; TERATOMA; TESTIS CANCER; YOLK SAC TUMOR;

ANIMALIA;

EID: 69549120182     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr_00000131     Document Type: Review

References (20)

1. Sano H, Kawahito Y, Wilder RL, et al: Expression of cyclooxygenase-1 and -2 in human colorectal cancer. Cancer Res 55: 3785-3789, 1995.
2. Yoshimura R, Matsuyama M, Tsuchida K, Kawahito Y, Sano H and Nakatani T: Expression of lipoxygenase in human bladder carcinoma and growth inhibition by its inhibitors. J Urol 170: 1994-1999, 2003.
3. Xie W, Chipman JG, Robertson DL, Erikson RL and Simmons DL: Expression of a mitogen-responsive gene encoding prostaglandin synthase is regulated by mRNA splicing. Proc Natl Acad Sci USA 88: 2692-2696, 1991. (Pubitemid 21916484)
4. Sigal E: The molecular biology of mammalian arachidonic acid metabolism. Am J Physiol 260: 13-28, 1991.
5. Funk CD: The molecular biology of mammalian lipoxygenases and the quest for eicosanoid functions using lipoxygenase-deficient mice. Biochim Biophys Acta 1304: 65-84, 1996.
6. Matsuyama M, Hayama T, Funao K, et al: Overexpression of cysteinylLT1 receptor in prostate cancer and CysLT1R antagonist inhibits prostate cancer cell growth through apoptosis. Oncol Rep 18: 99-104, 2007.
7. Issemann I and Green S: Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferator. Nature 347: 645-650, 1990. (Pubitemid 20356241)
8. Braissant O, Foufelle F, Scotto C, Dauca M and Wahli W: Differential expression of peroxisome proliferator-activated receptors (PPARs). Tissue distribution of PPAR-alpha, -beta, and -gamma in the adult rat. Endocrinology 137: 354-366, 1996.
9. Mukherjee R, Jow L, Croston GE and Paterniti JR Jr: Identification, characterization, and tissue distribution of human peroxisome proliferator-activated receptor (PPAR) isoforms PPARgamma2 versus PPARgamma1 and activation with retinoid X receptor agonists and antagonists. J Biol Chem 272: 8071-8076, 1997. (Pubitemid 27137374)
10. Kawahito Y, Kondo M, Tsubouchi Y, et al: 15-deoxy-delta(12,14)-PGJ(2) induces synoviocyte apoptosis and suppresses adjuvant-induced arthritis in rats. J Clin Invest 106: 189-197, 2000.
11. Tsubouchi Y, Sano H, Kawahito Y, et al: Inhibition of human lung cancer cell growth by the peroxisome proliferator-activated receptor-γ agonists through induction of apoptosis. Biochem Biophys Res Commun 270: 400-405, 2000. (Pubitemid 30446848)
12. Inoue K, Kawahito Y, Tsubouchi Y, Kohno M, Yoshimura R, Yoshikawa T and Sano H: Expression of peroxisome proliferator-activated receptor gamma in renal cell carcinoma and growth inhibition by its agonists. Biochem Biophys Res Commun 287: 727-732, 2001. (Pubitemid 32912775)
13. Hase T, Yoshimura R, Matsuyama M, et al: Cyclooxygenase-1 and -2 in human testicular tumours. Eur J Cancer 39: 2043-2049, 2003.
14. Yoshimura R, Matsuyama M, Kawahito Y, et al: Study of cyclooxygenase-2 in renal cell carcinoma. Int J Mol Med 13: 229-233, 2004
15. Yoshimura R, Sano H, Mitsuhashi M, Kohno M, Chargui J and Wada S: Expression of cyclooxygenase-2 in patients with bladder carcinoma. J Urol 165: 1468-1472, 2001. (Pubitemid 32410216)
16. Yoshimura R, Sano H, Masuda C, et al: Expression of cyclooxygenase-2 in prostate carcinoma. Cancer 89: 589-596, 2000. (Pubitemid 30640105)
17. Hwang D, Scollard D, Byrne J and Levine E: Expression of cyclooxygenase-1 and cyclooxygenase-2 in human breast cancer. J Natl Cancer Inst 90: 455-460, 1998. (Pubitemid 28160637)
18. Yoshimura R, Matsuyama M, Mitsuhashi M, et al: Relationship between lipoxygenase and human testicular cancer. Int J Mol Med 13: 389-393, 2004.
19. Goto HG, Nishizawa Y, Katayama H, et al: Induction of apoptosis in an estrogen-responsive mouse Leydig tumor cell by leukotriene. Oncol Rep 17: 225-232, 2007.
20. Hase T, Yoshimura R, Mitsuhashi M, et al: Expression of peroxisome proliferator-activated receptors in human testicular cancer and growth inhibition by its agonists. Urology 60: 542-547, 2002. (Pubitemid 35292201)